Skip to main content
Fachgebiete
Automobil + Motoren Bauwesen + Immobilien Business IT + Informatik Elektrotechnik + Elektronik Energie + Nachhaltigkeit Finance + Banking Management + Führung Marketing + Vertrieb Maschinenbau + Werkstoffe Versicherung + Risiko
DE
EN
Themenseiten
Organisationspsychologie Projektmanagement Marketing Smart Manufacturing
Bücher
Zeitschriften
Weitere Formate
Podcasts Webinare Technik Webinare Wirtschaft Kongresse Veranstaltungskalender Awards
Jetzt Einzelzugang starten
Zugang für Unternehmen
Referenzkunden
MTZ-Fachkongress

Antriebe und Energiesysteme von morgen


Austausch von Automobil- und Energiewirtschaft

Am 14./15. Mai geht es in Chemnitz um die Mobilitätswende durch Elektro- und Wasserstofffahrzeuge.
Erweiterte Suche
Anmelden
nach oben
Quality of Life Research
Erschienen in: Quality of Life Research 5/2007

01.06.2007 | Original Paper

Low level of quality of life in patients with mental and behavioral disorders wanting complementary and alternative (kampo) therapy

verfasst von: Kazuo Yamada

Erschienen in: Quality of Life Research | Ausgabe 5/2007

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Objective

To compare the quality of life (QOL) in patients with and without mental and behavioral disorders wanting to receive kampo, a type of complementary and alternative medicine (CAM), we investigated the QOL of patients using the World Health Organization Quality of Life Brief Scale (WHOQOL-BREF).

Methods

Seven hundred and twenty-nine outpatients with various diseases or disorders wanting to receive kampo therapy were recruited in the study. Two hundred and ninety-four patients (F-group) had mental or behavioral disorders. For these 729 patients, QOL was rated on the WHOQOL-BREF Japanese version.

Results

The average WHOQOL-BREF score of F-group (2.93 ± .54) was significantly lower than that of controls (3.23 ± .53). Especially, the average WHOQOL-BREF score of the 135 patients who had already been treated with modern medicines and wanted to be treated with kampo formulas to augment modern medicines (2.77 ± .55) was significantly lower than that of other patients.

Conclusion

QOL in patients with mental and behavioral disorders wanting to be treated with kampo who had already been treated with modern medicines was lower than that in patients with general medical conditions or with mental or behavioral disorders not treated with modern medicine.
Vorheriger Artikel The relationship between gender, social support, and health-related quality of life in a community-based study in Washington County, Maryland
Nächster Artikel Quality of life in couples living with Huntington’s disease: the role of patients’ and partners’ illness perceptions

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Jetzt informieren
Literatur
1.
Astin, J. A. (1998). Why patients use alternative medicine: Results of a national study. Journal of American Medical Association, 279, 1548–1553.CrossRef
2.
Burstein, H. J., Gelber, S., & Guadagnoli, E. et al. (1999). Use of alternative medicine by women with early-stage breast cancer. New England Journal of Medicine, 340, 1733–1739.PubMedCrossRef
3.
Eisenburg, D. M., Davis, R. B., & Ettner, S. L. et al. (1998). Trends in alternative medicine use in the United States, 1990–1997: Results of a follow-up national survey. Journal of American Medical Association, 280, 1569–1575.CrossRef
4.
Ernst, E. (2000). Prevalence of use of complementary/alternative medicine: A systematic review. Bulletin of the World Health Organization, 78, 252–257.PubMed
5.
Kanba, S., Yamada, K., & Mizushima, H. et al. (1999). Use of herbal medicine for treating psychiatric disorders in Japan. In S. Kanba & E. Richelson (Eds.), Herbal medicine for neuropsychiatric diseases (pp. 3–13). New York: Seiwa Shoten/Brunner-Mazel.
6.
Mizushima, H., & Kanba, S. (1999). The use of Japanese herbal medicine in the treatment of medically unexplained physical symptoms. Journal of Psychosomatic Research, 46, 531–535.PubMedCrossRef
7.
Nakane, Y., Tazaki, M., & Miyaoka, E. (1999). WHOQOL-BREF survey of general population. Iryo-to-Shakai, 9, 123–131 (in Japanese).
8.
Rickhi, B., Quan, H., & Moritz, S. et al. (2003). Mental disorders and reasons for using complementary therapy. Canadian Journal of Psychiatry, 48, 475–479.
9.
Saxena, S., Carlson, D., & Billington, R. et al. (2001). The WHO quality of life assessment instrument (WHOQOL-Bref): The importance of its items for cross-cultural research. Quality of Life Research, 10, 711–721.PubMedCrossRef
10.
Terasawa, K. (1993). Kampo, Japanese oriental medicine. Tokyo: KK Standard McIntyre.
11.
The WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28, 551–558.CrossRef
12.
The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHO-QOL). (1998). Development and general psychometric properties. WHO/MNH/PSF/97.4. Geneva: WHO.
13.
Wang, J. L., Patten, S. B., & Russell, M. L. (2001). Alternative medicine use by individuals with major depression. Canadian Journal of Psychiatry, 46, 528–533.
14.
Yamada, K., Den, R., & Ohnishi, K. et al. (2005). Effectiveness of herbal medicine (kampo) and changes of quality of life in patients with somatoform disorders. Journal of Clinical Psychopharmacology, 25, 199–201.PubMedCrossRef
Metadaten
Titel
Low level of quality of life in patients with mental and behavioral disorders wanting complementary and alternative (kampo) therapy
verfasst von
Kazuo Yamada
Publikationsdatum
01.06.2007
Verlag
Kluwer Academic Publishers
Erschienen in
Quality of Life Research / Ausgabe 5/2007
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-007-9179-3

Weitere Artikel der Ausgabe 5/2007

Quality of Life Research 5/2007 Zur Ausgabe

Original Paper

Measuring social difficulties in routine patient-centred assessment: a Rasch analysis of the social difficulties inventory

Original Paper

Content comparison of health-related quality of life measures used in stroke based on the international classification of functioning, disability and health (ICF): a systematic review

Original Paper

Small-cell lung cancer patients are just ‘a little bit’ tired: response shift and self-presentation in the measurement of fatigue

Original Paper

Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon’s indices

Erratum

Health-related quality of life of firefighters and police officers 8.5 years after the air disaster in Amsterdam

Original Paper

Relation between level or change of hemoglobin and generic and disease-specific quality of life measures in hemodialysis

Premium Partner

    Bildnachweise